Publications by the researcher in collaboration with José Ramón González Juanatey (10)
2024
-
Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network
Cardiovascular Diabetology, Vol. 23, Núm. 1
2019
-
Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue
Pharmacological Research, Vol. 144, pp. 51-65
-
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180
2018
-
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
The Lancet, Vol. 392, Núm. 10157, pp. 1519-1529
2017
-
Cardiovascular efficacy and safety of bococizumab in high-risk patients
New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539
-
Evolution and bad prognostic value of advanced glycation end products after acute heart failure: Relation with body composition
Cardiovascular Diabetology, Vol. 16, Núm. 1
-
Non classical Monocytes Levels, Increased by Subcutaneous Fat-Secretome, Are Associated with Less Rehospitalization after Heart Failure Admission
Journal of Cardiovascular Translational Research, Vol. 10, Núm. 1, pp. 16-26
-
Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure
International Journal of Cardiology, Vol. 228, pp. 488-494
2006
-
Ghrelin In The Local Regulation Of Endocrine Glands
Handbook of Biologically Active Peptides (Elsevier Inc.), pp. 869-875
2005
-
Ghrelin, the Same Peptide for Different Functions: Player or Bystander?
Vitamins and Hormones, Vol. 71, pp. 405-432